Mogy Joel R Investment Counsel’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-31,006
| Closed | -$15.4M | – | 128 |
|
|
2025
Q1 | $15.4M | Buy |
31,006
+3,374
| +12% | +$1.68M | 0.99% | 26 |
|
|
2024
Q4 | $14.4M | Buy |
27,632
+1,071
| +4% | +$557K | 0.85% | 29 |
|
|
2024
Q3 | $16.4M | Buy |
26,561
+656
| +3% | +$406K | 1.01% | 27 |
|
|
2024
Q2 | $14.3M | Buy |
25,905
+1,506
| +6% | +$833K | 0.91% | 28 |
|
|
2024
Q1 | $14.2M | Buy |
24,399
+1,378
| +6% | +$801K | 0.96% | 28 |
|
|
2023
Q4 | $12.2M | Sell |
23,021
-163
| -0.7% | -$86.5K | 0.92% | 29 |
|
|
2023
Q3 | $11.7M | Buy |
23,184
+642
| +3% | +$325K | 0.99% | 27 |
|
|
2023
Q2 | $11.8M | Buy |
22,542
+1,044
| +5% | +$545K | 0.93% | 29 |
|
|
2023
Q1 | $12.4M | Buy |
21,498
+528
| +3% | +$304K | 1.1% | 28 |
|
|
2022
Q4 | $11.5M | Buy |
20,970
+406
| +2% | +$224K | 1.16% | 28 |
|
|
2022
Q3 | $10.4M | Buy |
20,564
+387
| +2% | +$196K | 1.09% | 29 |
|
|
2022
Q2 | $11M | Buy |
20,177
+360
| +2% | +$196K | 1.08% | 31 |
|
|
2022
Q1 | $11.7M | Buy |
19,817
+510
| +3% | +$301K | 0.93% | 32 |
|
|
2021
Q4 | $12.9M | Buy |
19,307
+843
| +5% | +$562K | 0.92% | 32 |
|
|
2021
Q3 | $10.5M | Buy |
18,464
+843
| +5% | +$482K | 0.86% | 33 |
|
|
2021
Q2 | $8.89M | Buy |
17,621
+3,811
| +28% | +$1.92M | 0.75% | 33 |
|
|
2021
Q1 | $6.3M | Buy |
13,810
+5,478
| +66% | +$2.5M | 0.61% | 36 |
|
|
2020
Q4 | $3.88M | Buy |
8,332
+837
| +11% | +$390K | 0.38% | 42 |
|
|
2020
Q3 | $3.31M | Buy |
7,495
+1,371
| +22% | +$605K | 0.36% | 43 |
|
|
2020
Q2 | $2.22M | Buy |
+6,124
| New | +$2.22M | 0.27% | 48 |
|